Customized with genetic information from a patient’s own tumor, vaccines like this could one day be used against lung, kidney ...

A trial for the world’s first-ever mRNA cancer vaccine for melanoma is underway in the UK. Melanoma is the deadliest form of ...

The world’s first personalised vaccine for skin cancer is to be offered to British patients as part of a “cordon bleu” ...

Patients receiving pembrolizumab for metastatic urothelial carcinoma may be better served by taking H2RAs rather than PPIs, new research suggests.

Hookipa Pharma Inc., a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, announced its final pivotal phase 2/3 trial design for HB-200 in combination ...

Targeted therapies and immunotherapies across the ovarian, endometrial, and cervical cancers landscape play expanded roles, ...

The top 25 drugs ranked by nonfederal hospital expenditure in 2023: Bictegravir/emtricitabine/tenofovir/alafenamide — $643,390,000 (18.9% change) Pneumococcal vaccine conjugate — $585,635,000 (29.5% ...

An important trial of the world's first "personalised" mRNA vaccine against the deadliest form of skin cancer - melanoma - is ...

Meeting of ASCO is a major event for clinicians and researchers in the field of oncology. Explore more details here.

NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies to treat cancer, today announced ...

Final results of CORE-001 Phase 2 trial of cretostimogene in combination with pembrolizumab for the treatment of BCG-unresponsive NMIBC -IRVINE, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- , Inc.

During a Case-Based Roundtable® event, Moshe Ornstein, MD, MA, provided guidance on dosing and toxicity concerns in a patient ...